Nobilis Therapeutics, Inc. is a Delaware C-corporation that is focused on therapeutic uses of inert gas mixtures and development of portable devices for their self-administration.
Founded by a drug developer, a scientist and a pioneer of medical gas research, the Company has been able to capture the field and in a very short time has accomplished a tremendous amount. Nobilis Therapeutics has entered into an exclusive licensing agreement with Harvard University on the use of NBTX-001 to treat PTSD, filed 10 patents, and is well positioned to initiate 2 clinical trials in the coming months.
The Company has been able to attract a premier team of key opinion leaders to its scientific advisory board (link to SAB section) that have become instrumental in guiding its clinical development strategy.
Nobilis Therapeutics has completed the design of an inhalational device that will be used for its PTSD clinical trial at Harvard University and is actively working on the development of Zephyrus™, a portable hand-held device for self-administration of NBTX-001.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 3042 Nw Monte Vista Terrace Portland, Or 97210, Portland,oregon 97210,united States
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.nobilistx.com/
- HQ
- Portland, Oregon
Nobilis Therapeutics Questions
Nobilis Therapeutics's website is http://www.nobilistx.com/
Nobilis Therapeutics's LinkedIn profile is https://www.linkedin.com/company/nobilis-therapeutics
Nobilis Therapeutics has
2 employees.
View email and phone details for 2
employees at Nobilis Therapeutics.
Nobilis Therapeutics's industry is
Hospitals and Health Care
Nobilis Therapeutics's top competitors are
Sedia Biosciences Corp.,
Oregon Bioscience Incubator And Otradi,
Floragenex, Inc.,
Trace Biosciences,
Veana Therapeutics, Llc.,
Pdx Pharmaceuticals,
Agonox, Inc.,
Sparrow Pharmaceuticals, Inc.,
Cromos Pharma,
Ubivac.
Nobilis Therapeutics's categories are Hospitals and Health Care
Nobilis Therapeutics's founding year is 2016
